10-101227402-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006562.5(LBX1):āc.714C>Gā(p.Pro238=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,601,648 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0082 ( 23 hom., cov: 33)
Exomes š: 0.00098 ( 19 hom. )
Consequence
LBX1
NM_006562.5 synonymous
NM_006562.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0980
Genes affected
LBX1 (HGNC:16960): (ladybird homeobox 1) This gene and the orthologous mouse gene were found by their homology to the Drosophila lady bird early and late homeobox genes. In the mouse, this gene is a key regulator of muscle precursor cell migration and is required for the acquisition of dorsal identities of forelimb muscles. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 10-101227402-G-C is Benign according to our data. Variant chr10-101227402-G-C is described in ClinVar as [Benign]. Clinvar id is 780888.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.098 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00821 (1251/152334) while in subpopulation AFR AF= 0.028 (1166/41580). AF 95% confidence interval is 0.0267. There are 23 homozygotes in gnomad4. There are 624 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LBX1 | NM_006562.5 | c.714C>G | p.Pro238= | synonymous_variant | 2/2 | ENST00000370193.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LBX1 | ENST00000370193.4 | c.714C>G | p.Pro238= | synonymous_variant | 2/2 | 1 | NM_006562.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00821 AC: 1250AN: 152218Hom.: 23 Cov.: 33
GnomAD3 genomes
AF:
AC:
1250
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00211 AC: 467AN: 221654Hom.: 4 AF XY: 0.00175 AC XY: 216AN XY: 123246
GnomAD3 exomes
AF:
AC:
467
AN:
221654
Hom.:
AF XY:
AC XY:
216
AN XY:
123246
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000984 AC: 1426AN: 1449314Hom.: 19 Cov.: 31 AF XY: 0.000806 AC XY: 581AN XY: 720674
GnomAD4 exome
AF:
AC:
1426
AN:
1449314
Hom.:
Cov.:
31
AF XY:
AC XY:
581
AN XY:
720674
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00821 AC: 1251AN: 152334Hom.: 23 Cov.: 33 AF XY: 0.00838 AC XY: 624AN XY: 74492
GnomAD4 genome
AF:
AC:
1251
AN:
152334
Hom.:
Cov.:
33
AF XY:
AC XY:
624
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at